You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mTOR inhibitors

Showing 1 - 25 of 4,510
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

Not yet recruiting
  • Neuroendocrine Tumors
  • +4 more
  • Newport Beach, California
  • +2 more
Aug 16, 2023

HIV-infected Patient Kidney Transplant Recipient Trial (Biktarvy Tab)

Not yet recruiting
  • HIV-infected Patient Kidney Transplant Recipient
  • Biktarvy Tab
  • (no location specified)
Aug 3, 2021

Kidney Transplantation, Cytomegalovirus Infections Trial in L'Hospitalet de Llobregat (Switch from Mycophenolate Mofetil to

Not yet recruiting
  • Kidney Transplantation
  • Cytomegalovirus Infections
  • Switch from Mycophenolate Mofetil to Everolimus manteinance treatment in Active Comparator Arm
  • no intervention
  • L'Hospitalet de Llobregat, Barcelona, Spain
    Hospital Universitari de Bellvitge
Jun 16, 2021

Graft Vs Host Disease Trial in Toronto (Drug or biologic - anti-thymocyte globulin (ATG), extracorporeal photopheresis (ECP),

Recruiting
  • Graft Vs Host Disease
  • Drug or biologic - anti-thymocyte globulin (ATG), extracorporeal photopheresis (ECP), mTOR inhibitors (everolimus or sirolimus), vedolizumab, ruxolitinib.
  • Decidual Stromal Cells
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Feb 3, 2022

Solid Tumor, Adult, Hepatocellular Carcinoma Trial in Guangzhou (Combination of three inhibitors Trametinib, Everolimus and

Recruiting
  • Solid Tumor, Adult
  • Hepatocellular Carcinoma
  • Combination of three inhibitors Trametinib, Everolimus and Lenvatinib
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Apr 7, 2021

Bile Acids in Acute Insulin Resistance

Recruiting
  • PI3K Gene Mutation
  • +4 more
  • Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
  • New York, New York
    Columbia University Medical Center
Oct 6, 2022

Aging Trial in Madison (Sirolimus, Everolimus)

Not yet recruiting
  • Aging
  • Madison, Wisconsin
    University of Wisconsin
Jul 17, 2023

Aging Trial (Sirolimus)

Not yet recruiting
  • Aging
  • (no location specified)
Nov 3, 2022

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

Lymphangioleiomyomatosis (LAM) Trial in Nashville (Glutamine)

Completed
  • Lymphangioleiomyomatosis (LAM)
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Aug 10, 2021

Muscle Atrophy, Age-Related Sarcopenia Trial in Derby (Rapamune (sirolimus) 1Mg Tablet, Unilateral resistance exercise training)

Recruiting
  • Muscle Atrophy
  • Age-Related Sarcopenia
  • Rapamune (sirolimus) 1Mg Tablet
  • Unilateral resistance exercise training
  • Derby, United Kingdom
    University of Nottingham School of Medicine
Jun 7, 2022

Gallbladder Cancer Trial in Varanasi (Everolimus 10 mg, Standard of care)

Recruiting
  • Gallbladder Cancer
  • Everolimus 10 mg
  • Standard of care
  • Varanasi, UP, India
    Banaras Hindu University
Apr 18, 2023

Metastatic Breast Cancer Trial in France (Biopsy)

Completed
  • Metastatic Breast Cancer
  • Biopsy
  • Angers, France
  • +11 more
Sep 19, 2022

Drug-eluting Stent, Coronary Artery Disease Trial in Suwon (Genoss® DES system, Genoss® Osfit system)

Recruiting
  • Drug-eluting Stent
  • Coronary Artery Disease
  • Genoss® DES system, Genoss® Osfit system
  • Suwon, Korea, Republic of
    Ajou University Hospital
Sep 27, 2023

Breast Tumor, Breast Cancer, Hormone Receptor Positive Tumor Trial in Shanghai (PIK3CA inhibitor, AKT inhibitor, Carrelizumab)

Recruiting
  • Breast Neoplasm
  • +4 more
  • PIK3CA inhibitor
  • +12 more
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jan 2, 2023

Interstitial Fibrosis, Kidney Transplant; Complications, Kidney Transplant Rejection Trial in Houston (Fingolimod, Placebo)

Enrolling by invitation
  • Interstitial Fibrosis
  • +6 more
  • Houston, Texas
    Houston Methodist Research Institute
Jan 23, 2023

Lymphangioleiomyomatosis Trial in Milan (Nintedanib)

Completed
  • Lymphangioleiomyomatosis
  • Milan, Italy
    Pneumology unit
Sep 26, 2022

Kidney Cancer Trial run by the NCI (INC280)

Completed
  • Kidney Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 18, 2021

Epidermolysis Bullosa Simplex, Epidermolysis Bullosa Simplex Kobner, Weber-Cockayne Syndrome Trial in Palo Alto (Sirolimus, 2%,

Completed
Has Results
  • Epidermolysis Bullosa Simplex
  • +2 more
  • Palo Alto, California
    Stanford University
Feb 25, 2022

Kidney Cancer Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (cell infusion)

Recruiting
  • Kidney Cancer
  • cell infusion
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 2, 2022

Hepatocellular Carcinoma Trial in Belgium (Liver transplantation)

Recruiting
  • Hepatocellular Carcinoma
  • Liver transplantation
  • Antwerpen, Belgium
  • +5 more
Aug 27, 2022

Renal Transplantation Trial in France (Systematic transplantectomy, Progressive reduction of immunosuppression)

Completed
  • Renal Transplantation
  • Systematic transplantectomy
  • Progressive reduction of immunosuppression
  • Clermont-Ferrand Cedex, France
  • +8 more
Nov 18, 2022

Kaposiform Hemangioendothelioma, Tufted Angioma, Superficial Vascular Anomalies Trial in Shanghai (Percutaneous sirolimus, Oral

Recruiting
  • Kaposiform Hemangioendothelioma
  • +3 more
  • Percutaneous sirolimus
  • Oral sirolimus
  • Shanghai, China
    Children's Hospital of Fudan University
Jan 9, 2023

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

Active, not recruiting
  • Hypomelanotic Macules
  • +8 more
    • Tirana, Albania
    • +7 more
    Mar 23, 2022

    Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder), Chronic Lung Allograft Dysfunction Trial in

    Recruiting
    • Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder)
    • Chronic Lung Allograft Dysfunction
    • San Francisco, California
      University of California, San Francisco
    Aug 28, 2023